Animal capsule
Latest Eli Lilly and Company Patents:
- MODIFIED OLIGONUCLEOTIDES
- Oxyntomodulin binding molecules, and uses thereof
- Pharmaceutical combinations comprising insulin and at least an agent selected from meloxicam, bromfenac sodium, acetylsalicylic acid, salicyclic acid and paracetamol
- Cocrystalline forms of FGFR3 inhibitors
- Drug container systems including lock-out mechanisms
Description
FIG. 1 is a top plan view of an animal capsule showing our new design;
FIG. 2 is a front elevational view of the capsule, the opposite side being the same appearance;
FIG. 3 is a side elevational view of the capsule, the opposite side being the same appearance; and
FIG. 4 is a bottom plan view of the capsule.
Referenced Cited
U.S. Patent Documents
Other references
| 3548785 | December 1970 | Cooper |
| 3696787 | October 1972 | Cooper |
| 4160020 | July 3, 1979 | Ayer et al. |
- Thesis by Janet Macdonald, La Trobe University, Canada, titled "Sustained Release Capsules Containing Teric 18M10 and Monensin for the Control of Bloat and for Bodyweight Gain in Beef Cattle", title page and pp. 27 & 28, dated Nov. 1977.
Patent History
Patent number: D271623
Type: Grant
Filed: Apr 27, 1981
Date of Patent: Nov 29, 1983
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventors: Barbara E. Simpson (Indianapolis, IN), Norman A. Gervais (Hardy, VA)
Primary Examiner: Wallace R. Burke
Assistant Examiner: H. B. Fay, Jr.
Attorneys: Houston L. Swenson, Arthur R. Whale
Application Number: 6/258,223
Type: Grant
Filed: Apr 27, 1981
Date of Patent: Nov 29, 1983
Assignee: Eli Lilly and Company (Indianapolis, IN)
Inventors: Barbara E. Simpson (Indianapolis, IN), Norman A. Gervais (Hardy, VA)
Primary Examiner: Wallace R. Burke
Assistant Examiner: H. B. Fay, Jr.
Attorneys: Houston L. Swenson, Arthur R. Whale
Application Number: 6/258,223
Classifications
Current U.S. Class:
D28/2;
119/1
International Classification: D2801;
International Classification: D2801;
